Korean generic drugs and US healthcare reform

Published: 2008-11-11 07:00:00

Updated: 2008-11-11 07:00:00

Generic drugs made by Korean companies are not yet recognized as generic internationally, but under the US President-elect Barak Obama's universal healthcare coverage proposal, Korean firms make take advantage of this opportunity to enter the U.S. market, according to Moon Kyung-take, Vice Presid...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK